Printer Friendly

Cease, desist order on drug company's ads.

The Philippine Food and Drug Administration (FDA) has issued a summons with cease and desist order to pharmaceutical firm Sanofi Pasteur Inc. for airing television and radio s of its dengue vaccine, Dengvaxia.

In a statement, the FDA said the airing of the was in violation of Administrative Order No. 65 s. 1989, prohibiting in any form of prescription or ethical drug.

It said that the FDA Center for Drug Regulation and Research (CDRR) had monitored the airing of the advertising materials on dengue vaccination. It has also reported the unauthorized promotion of dengue vaccine in the malls.

In the summons issued by the FDA on Dec. 13, 2016, Sanofi was directed to cease and desist from disseminating s for Dengvaxia in any form of mass or social media. Sanofi was also directed to stop activities promoting and marketing the vaccine. However, as of Dec. 15, 2016, the FDA said the company had failed to comply with the FDA directive to take down the s.

'Since Sanofi has not complied, we have issued summons directing them to cease and desist from airing the s and show cause why they should not be penalized for violating the law,' FDA Director General Nela Charade G. Puno said in the statement.

Puno said that to ensure immediate compliance, 'the FDA had sent letters to TV and radio stations directing them not to air the said unauthorized ads.'

COPYRIGHT 2016 Asianet-Pakistan
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Philippines Daily Inquirer (Makati City, Philippines)
Date:Dec 28, 2016
Words:274
Previous Article:Biz buzz: Rearguard action at logistics firm.
Next Article:P1.36-B hydro power project in Mindanao OKd.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters